Boosting leukemia-specific T cell responses in patients following stem cell transplantation
Burkhardt, Ute E
MetadataShow full item record
CitationBurkhardt, Ute E., and Catherine J Wu. 2013. “Boosting leukemia-specific T cell responses in patients following stem cell transplantation.” Oncoimmunology 2 (11): e26587. doi:10.4161/onci.26587. http://dx.doi.org/10.4161/onci.26587.
AbstractWhole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patients subjected to allogeneic stem cell transplantation are discussed.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11879631
- HMS Scholarly Articles